Arthritis during interferon beta-1b treatment in multiple sclerosis

Multiple Sclerosis

Volumn 8, Issue 6, 2002, Pages 534-536

  Altintas, A ^a   Alici, Y ^a   Melikoglu M ^a   Siva, A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Arthritis; Interferons; Multiple sclerosis

Indexed keywords

HEMOGLOBIN; HLA ANTIGEN; INTERFERON BETA SERINE; METHOTREXATE; PREDNISOLONE; STEROID; ANTIRHEUMATIC AGENT; BETA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERFERON BETA-1B;

ADULT; ANKLE PAIN; ARTHRALGIA; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DIPLOPIA; DISEASE COURSE; DISEASE EXACERBATION; DYSARTHRIA; EDEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; KNEE PAIN; LEUKOCYTOSIS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; POLYARTHRITIS; PRESCRIPTION; RELAPSE; CHEMICALLY INDUCED DISORDER;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS; FEMALE; HUMANS; INTERFERON-BETA; METHOTREXATE; MULTIPLE SCLEROSIS; STEROIDS;

EID: 0036892699     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms852xx     Document Type: Article

References (23)

1. Moses H, Sriram S. Interferon beta and the cytokine trial. Where are we going? Neurology 1999; 52: 1729-30.
2. Young WV, Chabot S, Stuve O, et al. Interferon beta in the treatment of multiple sclerosis. Mechanism of action. Neurology 1988; 51: 682-89.
3. Schwid SR, Goodman AD, Mattson DH. Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b. Arch Neurol 1997 Sep; 54: 1169-70.
4. Cirelli R, Herne KB, McCrary ML, Tyring SK. Adverse effects of interferons. In Reder AT ed. Interferon therapy of multiple sclerosis. New York, NY: Marcel Dekker, 1997: 445-78.
5. Witt PL. Pharmacokinetics of interferon-beta and the biological markers it induces. In Reder AT ed. Interferon therapy of multiple sclerosis. New York, NY: Marcel Dekker, 1997: 77-93.
6. Polman CH, Herndon RM, Pozzilli C. Interferons. In Rudick RA, Goodkin DE eds. Multiple sclerosis therapeutics. London: Martin Dunitz, 1999: 243-76.
7. Walther EU, Hohlfield R. Multiple sclerosis: Side effects of interferon beta therapy and their management. Neurology 1999; 53: 1622-27.
8. Rotondi M, Mazziotti G, Biondi B, et al. Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease. J Endocrinol Invest 2000 May; 23: 321-24.
9. Cruz BA, Queiroz ED, Nunes SV, et al. Severe Raynaud's phenomenon associated with interferon-beta therapy for multiple sclerosis: case report. Arq Neuropsiquiatr 2000 Jun; 58: 556-59.
10. Créange A, Lefaucheur JP. Focal neuropathy associated with cutaneous necrosis at the site of interferon-beta injection for multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 68: 395.
11. Conlon C, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990 May; 65: 2237-42.
12. Rönnblom LE, Alm GV, Öberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115: 178-83.
13. Johnson DM, Hayat SQ, Burton GV. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma. J Rheumatol 1999 Apr; 26: 1009-10.
14. Ueno Y, Sohma T. Alpha-interferon induced rheumatoid arthritis in renal cell carcinoma. Ann Intern Med 1992 Aug 1; 117: 266-67.
15. Chazerain P, Meyer O, Kahn MF. Rheumatoid arthritis-like disease after alpha interferon therapy. Ann Internal Med 1992 March 1; 116: 427.
16. Imagawa A, Itoh N, Hanafusa T, et al. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis. J Clin Endocrinol Metab 1995; 80: 922-26.
17. Bosi E, Minelli R, Bazzigaluppi E, Salvi M. Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease? Diabetic Med 2001; 18: 329-32.
18. Zang YCQ, Yang D, Hong J, Tejada-Simon MW, Rivera VM, Zhang ZJ. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Neurology 2000 August 8; 55: 397-404.
19. Russo R, Tenenbaum S, Morena M, Battagliotti C. Interferon-beta 1a induced juvenile chronic arthritis in genetically predisposed young patient with multiple sclerosis: comment on the case report by Levesque et al. Arthritis Rheum 2000; 43: 1190.
20. Su L, David M. Inhibition of B cell receptor-mediated apoptosis by IFN. J Immunol 1999; 162: 6317-21.
21. Levesque MC, Ward FE, Jeffrey DR, Weinberg JB. Interferon-beta 1 A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele. Arthritis Rheum 1999 March; 42: 569-73.
22. Alsalameh S, Manger B, Kern P, Kalden J. New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson. Arthritis Rheum 1998; 41: 754.
23. Smeets TJ, Dayer JM, Kraan MC, et al. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis. Arthritis Rheum 2000 Feb; 43: 270-74.